Podcasts about propeller health

Mitch Robbins had the pleasure of hosting Mr. Jason Gorman, the Vice President of Regulatory, Quality & Compliance at Propeller Health for episode #105. Jason comes to us today with over 25 years of experience across the Med-Tech industry. He has a proven track record for developing & implementing Quality Management Systems, Risk Management strategies & Regulatory Compliance processes to meet the highest standards of excellence in customer satisfaction. Prior to working for Propeller Health, Jason spent over a decade working for Accuracy. For those unfamiliar with Propeller Health, now owned by Resmed, it's a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. The Propeller Platform includes FDA-cleared & CE Marked medical devices, consumer apps support & coaching and secure access to clinical data for provider monitoring.Some highlights:-Jason's journey into Quality & Regulatory-The evolution of his interest & responsibilities related to privacy & security-Cybersecurity's disruption to Med-Tech in relation MDR & QMSR changes-Jason's prediction for the evolution of Reg Affairs & Quality roles with regards to Cybesecurity-The relationship between Quality Management Systems & Information Security Management Systems-Cybersecurity vs AI....what is the common thread?...and so much more!Jason Gorman on LinkedIn:https://www.linkedin.com/in/jason-c-gorman/Propeller Health on the web:www.propellerhealth.com

In this episode, we hear from Susa Monacelli, General Manager at Propeller Health. In their own words Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. Topics include: The background to Propeller Health and the ResMed umbrella The original business hypothesis of ResMed and how this has evolved Patient experience using Propeller Health Differentiating propositions to health system, pharma and payers DTx vs. Disease Management 2.0 The future of prescription digital therapeutics Partnerships with health systems vs other routes to patient access Challenges holding the digital health industry back Guest Links and Resources: Connect with Susa Monacelli on LinkedIn Visit Propeller Health Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

About Pierre Leurent:Pierre Leurent, President of Aptar Digital Health, is the CEO and co-founder of Voluntis, a leading digital therapeutic company acquired by Aptar Group in 2021. Pierre has over 20 years of experience in digital health in the United States and Europe. Prior to starting Voluntis, he worked at GE Healthcare, in its medical imaging software division, and at HealthCenter Internet Services, a vendor of EMR solutions based in Silicon Valley. He is a founding Director of the Digital Therapeutics Alliance, of which he served as Chairman and a member of Advamed's Digital Health Executive Leadership Group. Pierre previously co-chaired the digital therapeutics task force of the Personal Connected Health Alliance, a member of HIMSS, and chaired the eHealth France Alliance. He holds an MS from Ecole Centrale Paris. About Sai Shankar:Sai has more than 20 years of experience across the pharmaceuticals, medical devices, and digital health business verticals. He has been an intrapreneur at Aptar, building the Digital Health division. Prior to joining Aptar in 2017, Sai worked for 15 years at Allergan and Sanofi.As the President of Aptar Digital Health, Sai is responsible for the overall P&L of the business. In addition to the organic growth of the connected devices business, he has overseen the acquisition of digital health companies (Voluntis and Cohero Health) as well as equity investments in various startups like Propeller Health, Sonmol (China), and Navia (India). Things You'll Learn:Voluntis was acquired by Aptar last year, a big investment on their part in the digital space.Aptar is a publicly traded company that makes technology to optimize the effectiveness and adherence of drugs across many therapeutic areas.Aptar Digital Health falls under the pharma segment of the Aptar organization.Digital technology can guide patients to help them self-manage and be more connected with their healthcare team remotely.Making data available to care teams remotely brings clinical benefits and generates savings for the healthcare system.Aptar Digital Health has one of the largest portfolios of collaborations in digital therapeutics in the global pharma market.Enhancing patient experiences lead to better engagement and in turn, outcomes. Resources:Connect with and follow Pierre Leurent on LinkedIn.Connect with and follow Sai Shankar on LinkedIn.Follow Aptar Digital Health on LinkedIn.Discover the Aptar Digital Health Website.

Propeller Health brings digital therapeutic expertise together with respiratory care experience to create solutions that improve patients' lives. General Manager Susa Monacelli joins Maria Whitman to give her perspective on how pharma companies can succeed on the new frontier of digital therapeutics. She also talks about the progress made so far in realizing the potential of digital therapeutics—and what still needs to be done—as well as the learning curves that may create barriers to adoption for providers and patients. Finally, she discusses the foundational questions that pharma should address before embarking on a digital therapeutic strategy.

Omada CEO Sean Duffy and Chris Hogg, former COO at Propeller Health, join host Jonah Comstock to talk about virtual care, remote chronic condition management, and just what healthcare will look like into the next decade. Talking points:What is virtual care?Virtual care in a post-COVID telehealth landscapeAdoption curves: virtual visits vs virtual careMulti-modal provider-patient communicationWhen the adoption curve lags against the innovation curveWhat’s the product? the transition from hardware to software to experienceUsing a jobs-to-be-done framework for healthcareHow to integrate virtual care with traditional brick-and-mortar careFitting virtual care into a patient-centric care ecosystemThe changing concept of primary careWhat virtual care companies have to offer for telemedicine (Sean’s non-answer on American Well)The role of Amazon, Walmart, and other big players in the new provider ecosystemHow traditional providers are reacting to the changing marketLooking aheadMore about this episode:MobiHealthNews' predictions for 2021: Price transparency tools will be a game changer, telemedicine use will even outAfter COVID-19, telehealth's momentum will be sustained by younger consumers seeking convenienceOmada reports blood sugar, weight improvements after 12 months with its digital diabetes prevention programOmada Health acquires Physera, adds virtual MSK therapy to its chronic care programsAmazon dives deeper into health in 2020Walmart snaps up digital health company CareZone's medication management toolAmwell CEO reflects on year of unprecedented telehealth adoption and predicts more digital chronic care for the futureRock Health's COO talks digital health funding, M&As and 'Teladongo'Previously on HIMSSCast: The Teladongo episode

I've known Greg Tracy since before founding Redox, connecting over civic hacking projects in Madison, Wisconsin. As the co-founder and CTO, Greg helped Propeller Health from its inception to serving patients across the globe and through its recent acquisition by ResMed (for $225M), where he now serves as the chief architect. Greg shares the Propeller Health story, their early choice to go through FDA clearance, and how they built the business into a global brand, as well as the constant struggle to prioritize projects, no matter how large the organization. He's always been a mentor to the up and coming developer-leaders in Madison; this conversation exemplifies this. Thanks for the great conversation Greg! 1:12 Overview of Propeller Health's product offering 3:09 Greg's background and starting Propeller 8:29 Balancing speed and quality in an FDA certified domain 11:57 Managing a diverse set of users and stakeholders 14:29 “Suck” meetings for engineering 16:59 Getting acquired by a public company 23:24 Prioritizing endless wants 27:19 How Slack fails product teams 30:00 The best innovation in healthcare comes from those without experience Find Greg on Twitter (@GregTracy).

I've known Greg Tracy since before founding Redox, connecting over civic hacking projects in Madison, Wisconsin. As the co-founder and CTO, Greg helped Propeller Health from its inception to serving patients across the globe and through its recent acquisition by ResMed (for $225M), where he now serves as the chief architect. Greg shares the Propeller Health story, their early choice to go through FDA clearance, and how they built the business into a global brand, as well as the constant struggle to prioritize projects, no matter how large the organization. He’s always been a mentor to the up and coming developer-leaders in Madison; this conversation exemplifies this. Thanks for the great conversation Greg!1:12 Overview of Propeller Health’s product offering3:09 Greg’s background and starting Propeller8:29 Balancing speed and quality in an FDA certified domain11:57 Managing a diverse set of users and stakeholders14:29 “Suck” meetings for engineering16:59 Getting acquired by a public company23:24 Prioritizing endless wants27:19 How Slack fails product teams30:00 The best innovation in healthcare comes from those without experienceFind Greg on Twitter (@GregTracy).

Jarred Shein joins us to talk digital health. Jarred has invested in digital health at MH Carnegie and Qure, an Israeli based VC fund. 0:20 - Introducing Jarred 1:00 - Jarred's education and background. 1:45 - Jarred's studies of nanotechnology, specifically biochemistry 2:30 - Jarred's thesis on biosensor devices and how it relates to Startrek 3:55 - End of university job with Macromatix, completely unrelated to biochemistry 5:10 - The early opportunity to pick up distressed medical device assets 6:00 - Australia's strong position in the world and relatively painless COVID-19 experience make it a great place for global healthcare 8:10 - Australia's unfortunate lack of a biochemistry talent pool 9:30 - Australia's amazing history of medical device companies, including Cochlear and Resmed 10:30 - The opportunity to invest in the digital health space in Australia 11:40 - Deep dive into Resmed (RMD:ASX) and its successful pivot to health data revenue 14:40 - The benefits of living and doing business in Australia 16:33 - The rise and rise of telehealth services, silencing industry doubters 18:50 - 'Ageing in Place' (getting older comfortably in the environment that you are in) is a really interesting growth space 21:25 - 'Digital Therapeutics' (clinically relevant personal solutions) is another compelling growth area (e.g. Propeller Health - a recent Resmed acquisition) 25:00 - Discussion of Click Therapeutics (digital therapeutics solutions for mental health issues) 26:55 - What happens when the 20 year patent life timer ends? 27:50 - Jarred's thoughts on Livongo (NASDAQ:LVGO), a Frazis Capital position 30:30 - Successful US healthcare business models rely on the US health insurance system 32:00 - The merger between Teladoc (NYSE:TDOC) and LVGO 34:00 - There should be a very tight communication channel between primary care and chronic disease management 35:25 - Do you book a telehealth consultation based on Brand? Doctor? Or Price? 37:30 - Today's best opportunities in digital health, both listed and unlisted 38:50 - Missed opportunity in American Well (NYSE:AMWL), a hot recent digital health IPO 40:10 - Lots of opportunities in the private space for digital health 40:45 - Early stage Australian digital health companies can only access capital by going public 41:35 - Jarred discusses a compelling Australian microcap digital health opportunity, Hera Med (ASX:HMD) 43:40 - Jarred introduces an interesting QLD telehealth service provider called Medicine, providing remote primary care services 45:00 - Some problems within the digital health industry - access to capital and talent, commercialising technology

Chris Hogg has an incredibly diverse background. He studied molecular biology at Brown University, worked in a basic science lab, and then went to business school at Booth. Chris went on to work in healthcare investment banking and in biotech at Gilead before transitioning to digital health. He founded 100Plus, where he was able to successfully secure EMR data and government contracts to try and change human behavior. We discuss the challenges he faced at this startup and his eventual transition to Propeller Health, where he was the Chief Commercialization Officer.

Joining me in our virtual studio is David Van Sickle, co-founder and CEO of Propeller Health. Propeller is a leading digital health company dedicated to the management of chronic respiratory disease. David founded Propeller Health in 2010 but he initially started his work in 2006 while at the University of Wisconsin in Madison.   David was one of the very early pioneers who spotted the ability to apply technology to medications to capture data that gives insights into both personal and population health. He and the team at propeller health worked tirelessly over the years to develop the technology, business models, regulatory approvals and evidence to drive adoption of their product.   Now, 14 years on, and this early digital health company is seeing a groundswell of interest as their products are used by some of the people who are most vulnerable to COVID-19. I wanted to know how their strong foundation and company mission supported their growth and evolution, and how, with their successful track record, they are supporting their users and communities to help them stay well and healthy. I was also interested to see if they’ve observed any changes in behavior by their users in the wake of the coronavirus pandemic. Links and Resources: Connect with David Van Sickle: Twitter | LinkedIn Connect with Propeller Health: Website | Twitter Nature Article "Improved asthma outcomes observed in the vicinity of coal power plant retirement, retrofit and conversion to natural gas" Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics Learn more about your ad choices. Visit megaphone.fm/adchoices

Chris Hogg Contributor Share on Twitter Chris Hogg is a digital health advocate interested in how new forms of health data are changing the relationship between physician and patient. As CCO of Propeller Health, he leads the company's San Francisco office and oversees the pharma BD, health system and payer sales, clinical and medical affairs and data science teams. Silicon Valley is obsessed with growth. And for digital health startups, that obsession is not only misguided, but dangerous.

Last time I looked this up online, there were more than 5000 companies offering digital medicine tools. Which ones worked? Which ones are less good than others? Which ones have not been tested? How were they tested: apples to apples or a whole fruit basket of standards? If you’re a clinician or the head of population health or an insurance carrier and you’re trying to figure out whether a digital tool could help solve a problem your patients are having … at this juncture, may the force be with you and I hope you know how to use Excel. The Digital Therapeutics Alliance (DTA) aims to put definitions and standards around what can be legitimately called a digital therapeutic and how these tools are best deployed so that patients are best equipped to get the best possible outcomes. Today I speak with Megan Coder, executive director of the Digital Therapeutics Alliance. You can learn more at dtxalliance.org. Megan Coder, PharmD, MBA, is executive director of the Digital Therapeutics Alliance (DTA), whose mission is to broaden the understanding, adoption, and integration of clinically validated digital therapeutic solutions into mainstream health care through education, advocacy, and research. With more than a decade of experience in the health care industry, Megan’s expertise extends from strategic growth and partnership development within the digital health sector to the direct delivery of patient care. 01:50 What the Digital Therapeutics Alliance is. 02:59 Defining a digital therapeutic. 03:50 What is vs what isn’t a digital therapeutic. 05:08 What it means to be a digital therapeutic. 06:19 Extending clinical care to a patient outside of the clinical care environment. 07:54 Digital therapeutics Megan is currently excited about. 10:48 Learn more about WellDoc with Anand Iyer in EP102. 11:02 Learn more about Propeller Health in EP32 with Kevin Houlihan. 12:05 Digital therapeutics and digital formularies. 13:09 Managing and prescribing digital therapeutics on an individual patient level. 15:22 Why the DTA exists and the questions it’s answering. 18:09 Legitimate claims vs really good marketing. 20:34 “How do we start to clarify that process and bring a little … more continuity and consistency into this world?” 22:57 Disrupting without interrupting. 25:24 Megan’s advice to providers: knowing clinical needs and gaps. 27:31 Megan’s advice for insurance carriers. 28:32 Love the problem, not the solution. You can learn more at dtxalliance.org.

David Van Sickle, CEO & Co-Founder of Propeller Health, brings his public health background to health tech start-up Propeller Health. The company has created a line of sensors that work in conjunction with inhalers and spirometers to measure medication intake and breathing capacity of people with asthma. The start-up has undertaken some bold projects with entire cities including Louisville to demonstrate how tools such as these can benefit communities. In this podcast Van Sickle discusses the company's unique origins, its technology and a small hiccup involving the company's former name. Van Sickle will be speaking on an innovative panel at the May 31 Medtech Conference in Minneapolis.

David Van Sickle, CEO & Co-Founder of Propeller Health, brings his public health background to health tech start-up Propeller Health. The company has created a line of sensors that work in conjunction with inhalers and spirometers to measure medication intake and breathing capacity of people with asthma. The start-up has undertaken some bold projects with entire cities including Louisville to demonstrate how tools such as these can benefit communities. In this podcast Van Sickle discusses the company's unique origins, its technology and a small hiccup involving the company's former name. Van Sickle will be speaking on an innovative panel at the May 31 Medtech Conference in Minneapolis.

Today in FirstWord:

A great podcast with fellow Madisonian Mark Gehring, co-founder of HealthMyne and Propeller Health.

Kevin Houlihan is the Director of Client Experience at Propeller Health, a Madison, Wisconsin based respiratory health management technology company. Propeller Health has an FDA cleared platform for passive collection of information related to inhaled medications use paired with software interfaces and analytics. Prior to joining Propeller Health Kevin spent time bringing productivity to mobile tools in the configured building products software space. Kevin also spent several years at Dassault Systemes Solidworks focused on 3D mechanical design software. Kevin earned a B.S. in Mechanical Engineering from the University of Wisconsin in Madison, and an M.B.A. also from UW Madison. Kevin enjoys downhill skiing and has been active in competitive racing and coaching for many years. You can find out more about Propeller Health at http://propellerhealth.com, and connect via email at hello@propellerhealth.com. You can follow Propeller Health on Twitter @PropellerHealth and on facebook at https://www.facebook.com/PropellerHealth. You can follow Kevin on twitter @Houlihan_Kevin 00:00 Kevin talks the origin of Propeller Health.2:35 Where Propeller Health is today.3:45 How Kevin wound up at Propeller Health.5:00 How prevalent asthma and COPD are, yet remain two of the most overlooked and thus most expensive chronic diseases within healthcare.7:15 “If we're not helping patients understand how to use their medication, that's a huge roadblock to patient outcomes.”8:25 “People start down this path, and it gets worse and worse and worse, and they just learn to live with that.”9:30 What the target of evidence-based medicine is for asthma.10:20 The types of medication used to treat asthma or COPD11:10 How Propeller can track patient medication use, and the goal Propeller Health shoots for using this data.13:00 “The most expensive care is the kind that's given at the wrong time.”14:45 The lack of tools that Care Teams need to treat the right problems, and the issue of patients who don't track their progress because it's too time consuming.17:11 How the Propeller Health App can track, remind, interact, and connect patients and their family members and providers.18:30 The meta-data that the Propeller Health App tracks along with user data, in order to see a bigger picture and improve patient quality of life.20:20 Propeller Health is also able to use this data to find correlations between environment and broad increases in asthma triggers.22:10 How Propeller Health App reminders work.24:55 “The goal for us is to stay quiet until we have some significant insight to give you that you can do something with.”25:23 “The goal is to reduce the burden of managing and having your asthma or COPD.”31:00 Who hires Propeller Health.35:00 What Kevin thinks one critical success factor is for improving patient outcomes.38:00 Check out propellerhealth.com for more information and to reach Kevin.

00:00 Intro Music “Alone But Not Lonely” by Stefan Ternemar 00:11 Intro by John Breslin @johnbreslin, Marie Boran @PixievVonDust, Jack Harty, Andrii Degeler @shlema, Tom Murphy @tom_murphy 00:01 Shout outs: Irish Executive Mentoring Program http://www.iemp.org FlirtFM http://flirtfm.ie 01:37 News Section: 01:45 Dublin Web Summit http://websummit.net 03:17 Jay Bregman on Drones @jaybregman Ireland well poised to be a leader in Drone tech - discussion. 06:44 Driverless Cars - piloted cars discussion. 08:44 Amendments to Article 8 and Article 39 of 1968 Convention on Road Traffic http://www.unece.org/fileadmin/DAM/trans/doc/2014/wp1/ECE-TRANS-WP1-145e.pdf Annex Page 9. 09:44 Audi Pilotless cars Andreas Reich - Head of Electronic Predevelopment http://blog.websummit.net/audi-web-summit-2014/ discussion. 13:30 Wearable fitness devices are not used over the long term. http://fortune.com/2014/05/08/fitness-trackers-are-on-the-outs-but-wearables-are-not/ 19:30 Walkmeter https://abvio.com/walkmeter/ 20:25 Jawbone Up https://jawbone.com/up 20:32 Fitbit Flex http://www.fitbit.com/flex 20:44 StepTracker https://itunes.apple.com/us/app/steptracker-fitness-pedometer/id714439468?mt=8 21:05 FuelBand http://www.nike.com/us/en_us/c/nikeplus-fuelband 22:30 Propeller Health http://propellerhealth.com/solutions/ 23:00 Tech Finance: Jack Harty discusses the National Policy Statement on Entrepreneurship in Ireland http://www.enterprise.gov.ie/en/Publications/National%20Policy%20Statement%20on%20Entrepreneurship%20in%20Ireland.pdf 30:33 #DigiWomen http://digi-women.com 50:07 Cool Tech: 50;15 Microsoft Band http://www.microsoft.com/microsoft-band/en-us 56:11 Amazon Echo http://www.amazon.com/oc/echo/ref_=ods_dp_ae 57:25 i3 BMW Video https://www.youtube.com/watch?v=mwi10ZCXRrA&spfreload=10&channel=technologyvoice 57:34 Onyx Walkie Talkie by OnBeep http://www.onbeep.com/order/onyx 58:57 Wrap Up 59:25 End of speech portion. Outro music “Alone But Not Lonely” by Stefan Ternemar 60:00 End